Loading…

Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease

The basal ganglia (BG) are a highly organized network, where different parts are activated for specific functions and circumstances. The BG are involved in movement control, as well as associative learning, planning, working memory, and emotion. We concentrate on the “motor circuit” because it is th...

Full description

Saved in:
Bibliographic Details
Published in:Movement disorders 2008, Vol.23 (S3), p.S548-S559
Main Authors: Obeso, Jose A., Rodríguez-Oroz, Maria Cruz, Benitez-Temino, Beatriz, Blesa, Franscisco J., Guridi, Jorge, Marin, Concepció, Rodriguez, Manuel
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4582-32b9ecfc6077f158176abdc5aa9ed069c58d6fcce4afa5cbcf685cd466dbabc83
cites cdi_FETCH-LOGICAL-c4582-32b9ecfc6077f158176abdc5aa9ed069c58d6fcce4afa5cbcf685cd466dbabc83
container_end_page S559
container_issue S3
container_start_page S548
container_title Movement disorders
container_volume 23
creator Obeso, Jose A.
Rodríguez-Oroz, Maria Cruz
Benitez-Temino, Beatriz
Blesa, Franscisco J.
Guridi, Jorge
Marin, Concepció
Rodriguez, Manuel
description The basal ganglia (BG) are a highly organized network, where different parts are activated for specific functions and circumstances. The BG are involved in movement control, as well as associative learning, planning, working memory, and emotion. We concentrate on the “motor circuit” because it is the best understood anatomically and physiologically, and because Parkinson's disease is mainly thought to be a movement disorder. Normal function of the BG requires fine tuning of neuronal excitability within each nucleus to determine the exact degree of movement facilitation or inhibition at any given moment. This is mediated by the complex organization of the striatum, where the excitability of medium spiny neurons is controlled by several pre‐ and postsynaptic mechanisms as well as interneuron activity, and secured by several recurrent or internal BG circuits. The motor circuit of the BG has two entry points, the striatum and the subthalamic nucleus (STN), and an output, the globus pallidus pars interna (GPi), which connects to the cortex via the motor thalamus. Neuronal afferents coding for a given movement or task project to the BG by two different systems: (1) Direct disynaptic projections to the GPi via the striatum and STN. (2) Indirect trisynaptic projections to the GPi via the globus pallidus pars externa (GPe). Corticostriatal afferents primarily act to inhibit medium spiny neurons in the “indirect circuit” and facilitate neurons in the “direct circuit.” The GPe is in a pivotal position to regulate the motor output of the BG. Dopamine finely tunes striatal input as well as neuronal striatal activity, and modulates GPe, GPi, and STN activity. Dopaminergic depletion in Parkinson's disease disrupts the corticostriatal balance leading to increased activity the indirect circuit and reduced activity in the direct circuit. The precise chain of events leading to increased STN activity is not completely understood, but impaired dopaminergic regulation of the GPe, GPi, and STN may be involved. The parkinsonian state is characterized by disruption of the internal balance of the BG leading to hyperactivity in the two main entry points of the network (striatum and STN) and excessive inhibitory output from the GPi. Replacement therapy with standard levodopa creates a further imbalance, producing an abnormal pattern of neuronal discharge and synchronization of neuronal firing that sustain the “off” and “on with dyskinesia” states. The effect of levodopa is robust but
doi_str_mv 10.1002/mds.22062
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69564500</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69564500</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4582-32b9ecfc6077f158176abdc5aa9ed069c58d6fcce4afa5cbcf685cd466dbabc83</originalsourceid><addsrcrecordid>eNqFkEtvEzEURq0K1IS0i_6ByisQi0lsz_gRdiglAZE-pLZih3XHY6cu80jtGUH49Uya0K6qrq7uvef7FgehE0rGlBA2qYo4ZowIdoCGlKc0UYzLN2hIlOJJShUfoHcx3hNCKafiEA2okooKyYbo57yrTeubGkrchBXU_i9sV9w43N5ZnEPsP_19VXr4hG_ubIC17VpvsK_WpTePdMSuCfgKwi9fx6b-EHHho4Voj9BbB2W0x_s5QrfzLzezr8nycvFt9nmZmIwrlqQsn1rjjCBSOsoVlQLywnCAqS2ImBquCuGMsRk44CY3TihuikyIIofcqHSE3u9616F56GxsdeWjsWUJtW26qMWUi4wT8irItooyJnrw4w40oYkxWKfXwVcQNpoSvbWue-v60XrPnu5Lu7yyxTO519wDkx3w25d283KTPj-7_l-Z7BI-tvbPU6I3rIVMJdc_LhaaXMyXMrv6rs_Tf-YDnVM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21151426</pqid></control><display><type>article</type><title>Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Obeso, Jose A. ; Rodríguez-Oroz, Maria Cruz ; Benitez-Temino, Beatriz ; Blesa, Franscisco J. ; Guridi, Jorge ; Marin, Concepció ; Rodriguez, Manuel</creator><creatorcontrib>Obeso, Jose A. ; Rodríguez-Oroz, Maria Cruz ; Benitez-Temino, Beatriz ; Blesa, Franscisco J. ; Guridi, Jorge ; Marin, Concepció ; Rodriguez, Manuel</creatorcontrib><description>The basal ganglia (BG) are a highly organized network, where different parts are activated for specific functions and circumstances. The BG are involved in movement control, as well as associative learning, planning, working memory, and emotion. We concentrate on the “motor circuit” because it is the best understood anatomically and physiologically, and because Parkinson's disease is mainly thought to be a movement disorder. Normal function of the BG requires fine tuning of neuronal excitability within each nucleus to determine the exact degree of movement facilitation or inhibition at any given moment. This is mediated by the complex organization of the striatum, where the excitability of medium spiny neurons is controlled by several pre‐ and postsynaptic mechanisms as well as interneuron activity, and secured by several recurrent or internal BG circuits. The motor circuit of the BG has two entry points, the striatum and the subthalamic nucleus (STN), and an output, the globus pallidus pars interna (GPi), which connects to the cortex via the motor thalamus. Neuronal afferents coding for a given movement or task project to the BG by two different systems: (1) Direct disynaptic projections to the GPi via the striatum and STN. (2) Indirect trisynaptic projections to the GPi via the globus pallidus pars externa (GPe). Corticostriatal afferents primarily act to inhibit medium spiny neurons in the “indirect circuit” and facilitate neurons in the “direct circuit.” The GPe is in a pivotal position to regulate the motor output of the BG. Dopamine finely tunes striatal input as well as neuronal striatal activity, and modulates GPe, GPi, and STN activity. Dopaminergic depletion in Parkinson's disease disrupts the corticostriatal balance leading to increased activity the indirect circuit and reduced activity in the direct circuit. The precise chain of events leading to increased STN activity is not completely understood, but impaired dopaminergic regulation of the GPe, GPi, and STN may be involved. The parkinsonian state is characterized by disruption of the internal balance of the BG leading to hyperactivity in the two main entry points of the network (striatum and STN) and excessive inhibitory output from the GPi. Replacement therapy with standard levodopa creates a further imbalance, producing an abnormal pattern of neuronal discharge and synchronization of neuronal firing that sustain the “off” and “on with dyskinesia” states. The effect of levodopa is robust but short‐lasting and converts the parkinsonian BG into a highly unstable system, where pharmacological and compensatory effects act in opposing directions. This creates a scenario that substantially departs from the normal physiological state of the BG. © 2008 Movement Disorder Society</description><identifier>ISSN: 0885-3185</identifier><identifier>EISSN: 1531-8257</identifier><identifier>DOI: 10.1002/mds.22062</identifier><identifier>PMID: 18781672</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Afferent Pathways - pathology ; Afferent Pathways - physiopathology ; Animals ; Antiparkinson Agents - therapeutic use ; basal ganglia ; Basal Ganglia - anatomy &amp; histology ; Basal Ganglia - pathology ; Basal Ganglia - physiopathology ; Cerebral Cortex - pathology ; Cerebral Cortex - physiopathology ; Corpus Striatum - pathology ; Corpus Striatum - physiopathology ; globus pallidus ; Globus Pallidus - pathology ; Globus Pallidus - physiopathology ; Haplorhini ; Humans ; medium spiny neurons ; Models, Animal ; Models, Neurological ; Parkinson Disease - drug therapy ; Parkinson Disease - pathology ; Parkinson Disease - physiopathology ; parkinson's disease ; striatum ; subthalamic nucleus</subject><ispartof>Movement disorders, 2008, Vol.23 (S3), p.S548-S559</ispartof><rights>Copyright © 2008 Movement Disorder Society</rights><rights>(c) 2008 Movement Disorder Society.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4582-32b9ecfc6077f158176abdc5aa9ed069c58d6fcce4afa5cbcf685cd466dbabc83</citedby><cites>FETCH-LOGICAL-c4582-32b9ecfc6077f158176abdc5aa9ed069c58d6fcce4afa5cbcf685cd466dbabc83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18781672$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Obeso, Jose A.</creatorcontrib><creatorcontrib>Rodríguez-Oroz, Maria Cruz</creatorcontrib><creatorcontrib>Benitez-Temino, Beatriz</creatorcontrib><creatorcontrib>Blesa, Franscisco J.</creatorcontrib><creatorcontrib>Guridi, Jorge</creatorcontrib><creatorcontrib>Marin, Concepció</creatorcontrib><creatorcontrib>Rodriguez, Manuel</creatorcontrib><title>Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease</title><title>Movement disorders</title><addtitle>Mov. Disord</addtitle><description>The basal ganglia (BG) are a highly organized network, where different parts are activated for specific functions and circumstances. The BG are involved in movement control, as well as associative learning, planning, working memory, and emotion. We concentrate on the “motor circuit” because it is the best understood anatomically and physiologically, and because Parkinson's disease is mainly thought to be a movement disorder. Normal function of the BG requires fine tuning of neuronal excitability within each nucleus to determine the exact degree of movement facilitation or inhibition at any given moment. This is mediated by the complex organization of the striatum, where the excitability of medium spiny neurons is controlled by several pre‐ and postsynaptic mechanisms as well as interneuron activity, and secured by several recurrent or internal BG circuits. The motor circuit of the BG has two entry points, the striatum and the subthalamic nucleus (STN), and an output, the globus pallidus pars interna (GPi), which connects to the cortex via the motor thalamus. Neuronal afferents coding for a given movement or task project to the BG by two different systems: (1) Direct disynaptic projections to the GPi via the striatum and STN. (2) Indirect trisynaptic projections to the GPi via the globus pallidus pars externa (GPe). Corticostriatal afferents primarily act to inhibit medium spiny neurons in the “indirect circuit” and facilitate neurons in the “direct circuit.” The GPe is in a pivotal position to regulate the motor output of the BG. Dopamine finely tunes striatal input as well as neuronal striatal activity, and modulates GPe, GPi, and STN activity. Dopaminergic depletion in Parkinson's disease disrupts the corticostriatal balance leading to increased activity the indirect circuit and reduced activity in the direct circuit. The precise chain of events leading to increased STN activity is not completely understood, but impaired dopaminergic regulation of the GPe, GPi, and STN may be involved. The parkinsonian state is characterized by disruption of the internal balance of the BG leading to hyperactivity in the two main entry points of the network (striatum and STN) and excessive inhibitory output from the GPi. Replacement therapy with standard levodopa creates a further imbalance, producing an abnormal pattern of neuronal discharge and synchronization of neuronal firing that sustain the “off” and “on with dyskinesia” states. The effect of levodopa is robust but short‐lasting and converts the parkinsonian BG into a highly unstable system, where pharmacological and compensatory effects act in opposing directions. This creates a scenario that substantially departs from the normal physiological state of the BG. © 2008 Movement Disorder Society</description><subject>Afferent Pathways - pathology</subject><subject>Afferent Pathways - physiopathology</subject><subject>Animals</subject><subject>Antiparkinson Agents - therapeutic use</subject><subject>basal ganglia</subject><subject>Basal Ganglia - anatomy &amp; histology</subject><subject>Basal Ganglia - pathology</subject><subject>Basal Ganglia - physiopathology</subject><subject>Cerebral Cortex - pathology</subject><subject>Cerebral Cortex - physiopathology</subject><subject>Corpus Striatum - pathology</subject><subject>Corpus Striatum - physiopathology</subject><subject>globus pallidus</subject><subject>Globus Pallidus - pathology</subject><subject>Globus Pallidus - physiopathology</subject><subject>Haplorhini</subject><subject>Humans</subject><subject>medium spiny neurons</subject><subject>Models, Animal</subject><subject>Models, Neurological</subject><subject>Parkinson Disease - drug therapy</subject><subject>Parkinson Disease - pathology</subject><subject>Parkinson Disease - physiopathology</subject><subject>parkinson's disease</subject><subject>striatum</subject><subject>subthalamic nucleus</subject><issn>0885-3185</issn><issn>1531-8257</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNqFkEtvEzEURq0K1IS0i_6ByisQi0lsz_gRdiglAZE-pLZih3XHY6cu80jtGUH49Uya0K6qrq7uvef7FgehE0rGlBA2qYo4ZowIdoCGlKc0UYzLN2hIlOJJShUfoHcx3hNCKafiEA2okooKyYbo57yrTeubGkrchBXU_i9sV9w43N5ZnEPsP_19VXr4hG_ubIC17VpvsK_WpTePdMSuCfgKwi9fx6b-EHHho4Voj9BbB2W0x_s5QrfzLzezr8nycvFt9nmZmIwrlqQsn1rjjCBSOsoVlQLywnCAqS2ImBquCuGMsRk44CY3TihuikyIIofcqHSE3u9616F56GxsdeWjsWUJtW26qMWUi4wT8irItooyJnrw4w40oYkxWKfXwVcQNpoSvbWue-v60XrPnu5Lu7yyxTO519wDkx3w25d283KTPj-7_l-Z7BI-tvbPU6I3rIVMJdc_LhaaXMyXMrv6rs_Tf-YDnVM</recordid><startdate>2008</startdate><enddate>2008</enddate><creator>Obeso, Jose A.</creator><creator>Rodríguez-Oroz, Maria Cruz</creator><creator>Benitez-Temino, Beatriz</creator><creator>Blesa, Franscisco J.</creator><creator>Guridi, Jorge</creator><creator>Marin, Concepció</creator><creator>Rodriguez, Manuel</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>2008</creationdate><title>Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease</title><author>Obeso, Jose A. ; Rodríguez-Oroz, Maria Cruz ; Benitez-Temino, Beatriz ; Blesa, Franscisco J. ; Guridi, Jorge ; Marin, Concepció ; Rodriguez, Manuel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4582-32b9ecfc6077f158176abdc5aa9ed069c58d6fcce4afa5cbcf685cd466dbabc83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Afferent Pathways - pathology</topic><topic>Afferent Pathways - physiopathology</topic><topic>Animals</topic><topic>Antiparkinson Agents - therapeutic use</topic><topic>basal ganglia</topic><topic>Basal Ganglia - anatomy &amp; histology</topic><topic>Basal Ganglia - pathology</topic><topic>Basal Ganglia - physiopathology</topic><topic>Cerebral Cortex - pathology</topic><topic>Cerebral Cortex - physiopathology</topic><topic>Corpus Striatum - pathology</topic><topic>Corpus Striatum - physiopathology</topic><topic>globus pallidus</topic><topic>Globus Pallidus - pathology</topic><topic>Globus Pallidus - physiopathology</topic><topic>Haplorhini</topic><topic>Humans</topic><topic>medium spiny neurons</topic><topic>Models, Animal</topic><topic>Models, Neurological</topic><topic>Parkinson Disease - drug therapy</topic><topic>Parkinson Disease - pathology</topic><topic>Parkinson Disease - physiopathology</topic><topic>parkinson's disease</topic><topic>striatum</topic><topic>subthalamic nucleus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Obeso, Jose A.</creatorcontrib><creatorcontrib>Rodríguez-Oroz, Maria Cruz</creatorcontrib><creatorcontrib>Benitez-Temino, Beatriz</creatorcontrib><creatorcontrib>Blesa, Franscisco J.</creatorcontrib><creatorcontrib>Guridi, Jorge</creatorcontrib><creatorcontrib>Marin, Concepció</creatorcontrib><creatorcontrib>Rodriguez, Manuel</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Movement disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Obeso, Jose A.</au><au>Rodríguez-Oroz, Maria Cruz</au><au>Benitez-Temino, Beatriz</au><au>Blesa, Franscisco J.</au><au>Guridi, Jorge</au><au>Marin, Concepció</au><au>Rodriguez, Manuel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease</atitle><jtitle>Movement disorders</jtitle><addtitle>Mov. Disord</addtitle><date>2008</date><risdate>2008</risdate><volume>23</volume><issue>S3</issue><spage>S548</spage><epage>S559</epage><pages>S548-S559</pages><issn>0885-3185</issn><eissn>1531-8257</eissn><abstract>The basal ganglia (BG) are a highly organized network, where different parts are activated for specific functions and circumstances. The BG are involved in movement control, as well as associative learning, planning, working memory, and emotion. We concentrate on the “motor circuit” because it is the best understood anatomically and physiologically, and because Parkinson's disease is mainly thought to be a movement disorder. Normal function of the BG requires fine tuning of neuronal excitability within each nucleus to determine the exact degree of movement facilitation or inhibition at any given moment. This is mediated by the complex organization of the striatum, where the excitability of medium spiny neurons is controlled by several pre‐ and postsynaptic mechanisms as well as interneuron activity, and secured by several recurrent or internal BG circuits. The motor circuit of the BG has two entry points, the striatum and the subthalamic nucleus (STN), and an output, the globus pallidus pars interna (GPi), which connects to the cortex via the motor thalamus. Neuronal afferents coding for a given movement or task project to the BG by two different systems: (1) Direct disynaptic projections to the GPi via the striatum and STN. (2) Indirect trisynaptic projections to the GPi via the globus pallidus pars externa (GPe). Corticostriatal afferents primarily act to inhibit medium spiny neurons in the “indirect circuit” and facilitate neurons in the “direct circuit.” The GPe is in a pivotal position to regulate the motor output of the BG. Dopamine finely tunes striatal input as well as neuronal striatal activity, and modulates GPe, GPi, and STN activity. Dopaminergic depletion in Parkinson's disease disrupts the corticostriatal balance leading to increased activity the indirect circuit and reduced activity in the direct circuit. The precise chain of events leading to increased STN activity is not completely understood, but impaired dopaminergic regulation of the GPe, GPi, and STN may be involved. The parkinsonian state is characterized by disruption of the internal balance of the BG leading to hyperactivity in the two main entry points of the network (striatum and STN) and excessive inhibitory output from the GPi. Replacement therapy with standard levodopa creates a further imbalance, producing an abnormal pattern of neuronal discharge and synchronization of neuronal firing that sustain the “off” and “on with dyskinesia” states. The effect of levodopa is robust but short‐lasting and converts the parkinsonian BG into a highly unstable system, where pharmacological and compensatory effects act in opposing directions. This creates a scenario that substantially departs from the normal physiological state of the BG. © 2008 Movement Disorder Society</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>18781672</pmid><doi>10.1002/mds.22062</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0885-3185
ispartof Movement disorders, 2008, Vol.23 (S3), p.S548-S559
issn 0885-3185
1531-8257
language eng
recordid cdi_proquest_miscellaneous_69564500
source Wiley-Blackwell Read & Publish Collection
subjects Afferent Pathways - pathology
Afferent Pathways - physiopathology
Animals
Antiparkinson Agents - therapeutic use
basal ganglia
Basal Ganglia - anatomy & histology
Basal Ganglia - pathology
Basal Ganglia - physiopathology
Cerebral Cortex - pathology
Cerebral Cortex - physiopathology
Corpus Striatum - pathology
Corpus Striatum - physiopathology
globus pallidus
Globus Pallidus - pathology
Globus Pallidus - physiopathology
Haplorhini
Humans
medium spiny neurons
Models, Animal
Models, Neurological
Parkinson Disease - drug therapy
Parkinson Disease - pathology
Parkinson Disease - physiopathology
parkinson's disease
striatum
subthalamic nucleus
title Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T21%3A36%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Functional%20organization%20of%20the%20basal%20ganglia:%20Therapeutic%20implications%20for%20Parkinson's%20disease&rft.jtitle=Movement%20disorders&rft.au=Obeso,%20Jose%20A.&rft.date=2008&rft.volume=23&rft.issue=S3&rft.spage=S548&rft.epage=S559&rft.pages=S548-S559&rft.issn=0885-3185&rft.eissn=1531-8257&rft_id=info:doi/10.1002/mds.22062&rft_dat=%3Cproquest_cross%3E69564500%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4582-32b9ecfc6077f158176abdc5aa9ed069c58d6fcce4afa5cbcf685cd466dbabc83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=21151426&rft_id=info:pmid/18781672&rfr_iscdi=true